Haroutunian V - Search Results

1

Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.

Haroutunian V, Serby M, Purohit DP, Perl DP, Marin D, Lantz M, Mohs RC, Davis KL. Haroutunian V, et al. Arch Neurol. 2000 Aug;57(8):1145-50. doi: 10.1001/archneur.57.8.1145. Arch Neurol. 2000. PMID: 10927794

2

Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert.

Wallace WC, Bragin V, Robakis NK, Sambamurti K, VanderPutten D, Merril CR, Davis KL, Santucci AC, Haroutunian V. Wallace WC, et al. Among authors: haroutunian v. Brain Res Mol Brain Res. 1991 May;10(2):173-8. doi: 10.1016/0169-328x(91)90108-a. Brain Res Mol Brain Res. 1991. PMID: 1649369

3

Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease.

Perez N, Sugar J, Charya S, Johnson G, Merril C, Bierer L, Perl D, Haroutunian V, Wallace W. Perez N, et al. Among authors: haroutunian v. Brain Res Mol Brain Res. 1991 Oct;11(3-4):249-54. doi: 10.1016/0169-328x(91)90033-t. Brain Res Mol Brain Res. 1991. PMID: 1661822

4

Reduced in vitro phosphorylation of synapsin I (site 1) in Alzheimer's disease postmortem tissues.

Parks KM, Sugar JE, Haroutunian V, Bierer L, Perl D, Wallace WC. Parks KM, et al. Among authors: haroutunian v. Brain Res Mol Brain Res. 1991 Jan;9(1-2):125-34. doi: 10.1016/0169-328x(91)90137-m. Brain Res Mol Brain Res. 1991. PMID: 1850067

5

Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats.

Santucci AC, Haroutunian V, Davis KL. Santucci AC, et al. Among authors: haroutunian v. Clin Neuropharmacol. 1991;14 Suppl 1:S1-8. doi: 10.1097/00002826-199114001-00002. Clin Neuropharmacol. 1991. PMID: 1913705

6

Neurofibrillary tangles, Alzheimer's disease and Lewy bodies.

Bierer LM, Perl DP, Haroutunian V, Mohs RC, Davis KL. Bierer LM, et al. Among authors: haroutunian v. Lancet. 1990 Jan 20;335(8682):163. doi: 10.1016/0140-6736(90)90031-y. Lancet. 1990. PMID: 1967448 No abstract available.

7

Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.

Haroutunian V, Santucci AC, Davis KL. Haroutunian V, et al. Prog Brain Res. 1990;84:333-46. doi: 10.1016/s0079-6123(08)60917-6. Prog Brain Res. 1990. PMID: 1980019 No abstract available.

8

Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.

Haroutunian V, Kanof PD, Tsuboyama G, Davis KL. Haroutunian V, et al. Brain Res. 1990 Jan 22;507(2):261-6. doi: 10.1016/0006-8993(90)90280-o. Brain Res. 1990. PMID: 2110845

9

Differential brain expression of the Alzheimer's amyloid precursor protein.

Anderson JP, Refolo LM, Wallace W, Mehta P, Krishnamurthi M, Gotlib J, Bierer L, Haroutunian V, Perl D, Robakis NK. Anderson JP, et al. Among authors: haroutunian v. EMBO J. 1989 Dec 1;8(12):3627-32. doi: 10.1002/j.1460-2075.1989.tb08536.x. EMBO J. 1989. PMID: 2583112 Free PMC article.

10

Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.

Santucci AC, Haroutunian V, Tsuboyama GK, Kanof PD, Davis KL. Santucci AC, et al. Among authors: haroutunian v. Prog Clin Biol Res. 1989;317:1111-20. Prog Clin Biol Res. 1989. PMID: 2690088 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

421 results

Search Page